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Abstract The increasing number of nanotechnology
products on the market poses increasing human health
risks by particle exposures. Adverse effects of silver
nanoparticles (AgNPs) in various cell lines have been
measured based on exposure dose after a fixed time
point, but NP uptake kinetics and the time-dependent
internal cellular concentration are often not considered.
Even though knowledge about relevant timescales for
NP uptake is essential, e.g. for time- and cost-effective
risk assessment throughmodelling, insufficient data are
available. Therefore, the authors examined uptake rates
for three different AgNP sizes (20, 50 and 75 nm) and
two tissue culture medium compositions (with and
without foetal calf serum,FCS) under realistic exposure
concentrations in pulmonary epithelial 16HBE14o-
cells. The quantification of Ag in cells was carried out
by high-resolution inductively coupled plasma mass
spectrometry. We show for the first time that uptake
kinetics of AgNPs into 16HBE14o-cells was highly
influenced by medium composition. Uptake into cells
was higher in medium without FCS, reaching approx-
imately twice the concentration after 24 h than in
medium supplemented with FCS, showing highest
uptake for 50-nm AgNPs when expressed on a mass
basis. This optimum shifts to 20 nm on a number basis,
stressing the importance of the measurand in which
results are presented. The importance of our research
identifies that not just the uptake after a certain time
point should be considered as dose but also the process
of uptake (timing) might need to be considered when
studying the mechanism of toxicity of nanoparticles.
Keywords Nanoparticle  Uptake kinetics  Size
dependence  Internal cellular concentration  Serum
proteins  Health and safety effects  Biomedicine
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Introduction
Nanoparticles (NPs) are used in increasing amounts
and number of applications (Hendren et al. 2013;
Nowack and Bucheli 2007) due to their unique
physical and chemical properties. Consumer products
with NPs include toothpaste, wound dressings,
antibacterial towels and sportswear, as well as in
deodorants and in sprays for textiles and shoes
(Kuiken et al. 2014; Oomen et al. 2011; Vance et al.
2015; Wijnhoven et al. 2011). Of special interest for
consumer products, medical applications and industry
are silver nanoparticles (AgNPs), attributable, besides
others, to their antimicrobial properties. Several
in vitro studies showed that AgNPs affect various cell
lines, including phagocytizing cell like THP-1-derived
macrophages, and serious concerns about toxicolog-
ical and environmental effects have been raised
(Foldbjerg et al. 2009; Haase et al. 2011; Park et al.
2011; Singh and Ramarao 2012).
So, it can be concluded that adverse effects can
occur after contact with NPs. Exposure routes include
dermal, intestinal and inhalation uptake, whereas
injection may be used for nanomedicinal products.
Inhalation of AgNPs (aerosols) is possible by con-
sumers during product use (e.g. spray applications) or
by workers during the production and processing of
NPs (Maynard and Kuempel 2005). Also for AgNPs,
respiratory toxicity was reported in various animal
studies (Braakhuis et al. 2016a; Herzog et al. 2013; Ji
et al. 2007; Seiffert et al. 2015; Silva et al. 2015). On
the long term, the product containing the NPs may end
up in the environment through wash off, posing a
potential risk to human health and biota (Christensen
et al. 2010). Unfortunately, effects are often measured
after a single fixed time point based on exposure dose,
neglecting uptake kinetics and therefore time-depen-
dent internal cellular concentration. NP properties,
such as size, influence uptake as shown for various cell
lines in vitro. Unfortunately, uptake was detected only
after a fixed time point (He et al. 2010; Jiang et al.
2008; Lu et al. 2009; Rejman et al. 2004; Wang et al.
2010).
Small NPs can enter cells after contact via one of
the four exposure routes through a fundamental
biological process called endocytosis as previously
summarized (Kettler et al. 2014). Particulate matters,
such as proteins and other nutrients, are taken up into
eukaryotic cells via enclosure by the cell membrane
(Conner and Schmid 2003). Endocytosis is a form of
active transport. Endocytosis is usually employed by
non-phagocytic cells like 16HBE to take up biomo-
lecules from the environment. The cell membrane
forms itself around the molecules/particle to be taken
up, and the size of the resulting vesicles depends on the
presence of ligands and the protein involved in vesicle
formation (Doherty and McMahon 2009).
Macropinocytosis is a non-specific mechanism by
which the cell surrounding fluid and its content are
taken up in a concentration as present with vesicles
from 100 nm to 5 lm in size (Basu 1984). The other
pathways are receptor mediated, and uptake occurs
after binding of a ligand to specific receptors in the cell
surface, which results in uptake of the ligand in higher
concentration than in the medium. These pathways are
further distinguished by the protein involved in vesicle
formation. Vesicles in receptor-mediated endocytosis
reach sizes up to roughly 80 nm in diameter (i.d.)
(caveolae mediated) (Hirota and Terada 2012) or
120 nm i.d. (clathrin mediated) (Conner and Schmid
2003; Hirota and Terada 2012). Internalized NPs may
cause the production of reactive oxygen species due to
their effects on mitochondrial respiration (Xia et al.
2008), and antioxidant species might be depleted in
the cell (Park et al. 2008). Metals in the form of NPs
may employ this mechanism, and metal ions then may
enter cells by a so-called Trojan horse effect. Espe-
cially in the case of soluble metal particles, this can
result in high levels of the metal in various ionic
species inside the cell resulting in further reactions
(Limbach et al. 2007; Luoma 2008). By this mecha-
nism, AgNPs can enter cells and release toxic Ag ions
inside the cell ‘‘bypassing its barriers to ‘‘normal’’-
sized Ag and then releasing Ag ions that damage cell
machinery’’ (Lubick 2008), thereby increasing the
intracellular bioavailability of Ag. It was shown that
AgNPs can induce a higher toxic damage than Ag ions
(Lubick 2008; Park et al. 2011). As summarized
previously, several experimental conditions may
influence NP uptake (Kettler et al. 2014). In particular,
the presence or absence of serum proteins has been
shown to have great effects through the formation of a
so-called protein corona on the NPs surface. Uptake
can be increased, decreased or remain the same,
depending on the type of protein present (Ikada and
Tabata 1986; Krystek et al. 2015; Nagayama et al.
2007; Sbarra and Karnovsky 1959). In this study, we
aim to determine rates of uptake for different AgNP
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sizes and cell culture medium with and without serum
proteins, therefore exposing 16HBE14o-cells to NP
for different periods of time over 24 h. We apply NP
concentrations of 0.01 lg Ag/mL that represent real-
istic concentrations for short-term exposures (Gang-
wal et al. 2011). This concentration is much lower,
namely by a factor of up to 10,000, than in some of the
existing literature where uptake rates have been
determined (Huang et al. 2010; Shapero et al. 2010).
These data will deliver new insights into the effect of
NP size on their uptake rate and are required to model
and predict NP uptake rates based on easily measur-
able NP properties. Combining empirical data and
modelling will be an indispensable tool for time- and
cost-effective risk assessment of NPs.
Materials and methods
Nanomaterials
For non-phagocytic cells like 16HBE14o, a maximum
vesicle size of 80–120 nm has been found (Conner and
Schmid 2003; Hirota and Terada 2012); therefore,
three differently sized AgNPs were investigated in this
study: 20-nm citrate BioPureTM Silver, 50-nm citrate
BioPureTM Silver and 75-nm citrate BioPureTM Silver
were purchased from NanoComposix Inc (San Diego,
CA) in the form of stock dispersion with concentra-
tions of 1 mg/mL in aqueous 2 mM citrate buffer. The
supplier provided detailed information about the NPs
characteristics as summarized in Table 1. The diam-
eter was detected by the manufacturer NanoComposix
Inc using transmission electron microscopy (TEM)
(JEOL 1010 transmission electron microscope), and
the hydrodynamic diameter through dynamic light
scattering (DLS) (Malvern Zetasizer Nano ZS). The
material for TEM imaging is prepared by drying
nanoparticles on a copper grid; samples for DSL
measurements are undiluted in case of 20-nm AgNPs
and diluted with water by a factor of 10 and a factor of
20 for 50- and 75-nm AgNPs, respectively. According
to the supplied information, the NPs are stable for at
least 1 year; however, prolonged exposure to light
may change the material size. Accordingly, the NPs
were always kept out of light as much as possible, but
light exposure could not be completely prevented
during handling.
Preparation of AgNPs dispersions
Due to the significant effects, serum proteins present in
tissue culture growth medium may have on uptake,
these uptake studies were conducted with two types of
medium, with foetal calf serum (?FCS) and without
(w/o) the addition of FCS (Sbarra and Karnovsky
1959; Ikada and Tabata 1986; Nagayama et al. 2007).
The dilutions of AgNPs dispersions were performed in
complete tissue culture medium (see below), either
without or with FCS, prior to exposure. Final exposure
concentrations of 0.01 lg Ag/mL were obtained in
several steps and pre-dilutions: Per 1 mL medium,
10 lL of the NP dispersion was added for the first pre-
dilution and mixed thoroughly. This pre-dilution was
further diluted in three steps to reach the exposure
concentration of 0.01 lg Ag/mL. Two hundred micro-
liters of the final dilution was added to each well. We
used concentrations of 0.01 lg/mL at which no
change in metabolic toxicity has been shown in
16HBE14o-cells for NPs of the same type, from the
same manufacturer and same sizes (20 and 50 nm) in
the absence of FCS in order to study uptake in
uncompromised cells (Braakhuis et al. 2016b).
Cells and cell culture conditions
The human pulmonary epithelial cell line 16HBE14o
(kindly provided by Dr. Gruenert, USA) was used in
this study. 16HBE14o cells were cultured in Dul-
becco’s Modified Eagle Medium/Nutrient Mixture
F-12 ? GlutaMAX (DMEM/F-12, Gibco, the
Netherlands), supplemented with antibiotics (1 %
penicillin–streptomycin (Pen/Strep), Gibco, the
Netherlands) and 5 % foetal calf serum (FCS, Gibco,
the Netherlands) designated complete medium.
When the cells reached an 80–100 % confluent
monolayer, they were subcultured, usually 1:5 once a
week in new 75-mL tissue culture flasks (CellStar,
Greiner Bio-one, the Netherlands). 16HBE14o-cells
were harvested enzymatically using trypsin solution
(trypsin–EDTA (0.05 %) and phenol red, Gibco, the
Netherlands), counted, diluted and seeded into
96-well plates at cell densities of 60,000–65,000
cells/well 24 h before exposure to allow them to rest
and to reach 80–90 % confluence at the day of
exposure. Cells were constantly incubated at 37 C
and 5 % CO2 atmosphere.
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Cellular uptake of AgNPs
Cells were seeded in 96-well tissue culture plates as
described in ‘‘cell and cell culture conditions’’
section and exposed to 200 lL of 0.01 lg/mL
AgNP dispersions. The total exposure times were
0, 2, 4, 8, 12 and 24 h. At the end of exposure, cells
were thoroughly washed with Dulbecco’s phosphate-
buffered saline (DPBS, without calcium, magne-
sium, phenol red, Gibco, the Netherlands) twice to
remove loosely attached Ag ions and/or NPs from
the cell membrane. Two hundred microliters of
trypsin solution was added to detach the cells from
the bottom of the well. Through pipetting, it was
made sure that all cells were detached, and
successful detachment was confirmed by optical
inspection with a light microscope (magnification
509). Subsequently, the sample was transferred to
15-mL polystyrene centrifuge tubes (Corning Life
Sciences, the Netherlands) to be stored at 4 C until
their measurement of tightly attached and internal-
ized NPs. The samples were treated with 2 mL aqua
regia (nitric acid and ultrapure hydrochloric acid,
1:3, both from Merck, Germany) and further diluted
with ultrapure water to a final volume of 10 mL
prior to the determination of the total Ag concen-
tration (particle associated as well as ionic Ag) by
HR-ICP-MS-type ELEMENT XR, Thermo Fisher
Scientific, Bremen, Germany. The sample introduc-
tion systems consisted of a concentric nebulizer, a
cyclone spray chamber and nickel cones (all from
the instrument supplier). For the quantification,
external calibration with internal standard correction
(Rhodium as 103Rh?) was applied. Sample pre-
treatment and analysis were carried out in a clean
room facility class 10,000. Each experiment was
conducted independently two times for 50- and
75-nm AgNPs and once for 20-nm AgNPs.
Statistical evaluation and calculations
For the determination of uptake rate constants c and
elimination rate constants k, experimental results were
evaluated with Microsoft Excel 2010 and the corre-
sponding application ‘‘Solver’’ according to the one
compartment model using Eq. 1. Solver is a tool that
determines the optimal value for variables, here c and
k, within given limits in order to minimize differences
between experimental and model data.
c tð Þ ¼ c
k
 1 ekt  ð1Þ
where t is the time of exposure in hours; c is the uptake
rate constant in ng Ag well-1 d-1; and k is the
elimination rate constant in ng Ag well-1 d-1. Values
for k were set to a minimum of 10-8 in order to avoid
divisions by zero during the calculations, no other
limits are set. Ag concentrations were standardized to
a starting concentration of zero by subtracting the
initial concentration in the cells from the concentra-
tions in the cells at the later time point.
To convert the amount of Ag/well as detected by
HR-ICP-MS to assumed spherical NP numbers/well
(NP No/well), the formulas according to Chithrani
et al. (2006) were used.
Results
The original result of each sample point as well as the
model uptake curves is given in Fig. 1. Uptake did not
clearly level off during the time course for all samples.
For the 50- and 75-nm samples without FCS, the slope
of the uptake curve clearly became less steep with
time; the curve of the 75-nm samples with FCS
levelled off slightly. In our set-up the uptake of 50
AgNPs was higher for medium without FCS than in
Table 1 AgNP characteristics as provided by the manufacturer NanoComposix Inc
AgNP
product (nm)
Average
diameter (nm)
Coefficient of
variation (%)
SD
(nm)
Average hydrodynamic
diameter (nm)
Zeta
potential
(mV)
Mass concentration
(mg Ag/mL)
20 19.6 8.1 1.6 24.0 -30.4 1.09
50 53.5 8.3 4.4 56.0 -53.6 0.95
75 74.8 5.8 4.3 78.5 -37.6 0.99
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medium supplemented with FCS, reaching approxi-
mately twice the maximum concentration after 24 h of
exposure. Uptake was also faster, as represented by the
significantly different 95 % confidence interval of the
uptake rate constant c of 1.1 9 10-1–1.2 9 10-1 and
6.9 9 10-3–5.2 9 10-2 ng Ag well-1 d-1 without
and with FCS, respectively. For 20- and 75-nm
AgNPs, the same trend was observed but not as
pronounced, and the difference in uptake rates is
statistically not significant.
No differences in uptake, expressed as ng Ag per
well, for the three NP sizes could be observed in the
presence of FCS (Table 2); their uptake rate constants
were not significantly different. The mean of all three
AgNP sizes fell within the same narrow range.
Uptake in medium without FCS was faster, and a
size effect regarding the concentration at the latest
time point could be seen (Fig. 1, Figure S1), although
there is large variation between replicates. Uptake
expressed as mass was highest for AgNPs with a size
of 50 nm, reaching internal cell concentrations of
approximately 65 % of the nominal concentration,
followed by AgNPs of 75 and of 20 nm, each with
roughly 50 % Ag uptake. For the latter AgNP size,
only a single experiment was conducted, yet it did not
fall into the confidence interval of the 50-nm samples.
The uptake and elimination rates have been deter-
mined as presented in Tables 2 and S1, respectively.
For medium supplemented with FCS, no difference in
uptake rates could be detected (range
Fig. 1 Ag amount in cells on mass basis with the fitted line for
three NP sizes and medium without and with the addition of
foetal calf serum based on one and two independent experiments
for 20-, 50- and 75-nm particles, respectively. Note: Due to
logistic aspects, the time points at which the samples have been
obtained are slightly shifted sometimes (maximum 1 h)
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0.03–0.05 ng Ag well-1 d-1). The observed trend of
highest uptake for 50-nm AgNPs was not reflected in
the uptake rate, as the confidence intervals overlap for
50- and 75-nm AgNPs.
A size optimum based on particle numbers does not
necessarily lead to the same uptake optimum regard-
ing NP mass (Le´vy et al. 2010). To test whether this
was the case here as well, the values were converted to
particle numbers and their uptake rates compared. In
this case, a clear difference, represented by the slope,
was observed (Fig. 2). The uptake rate, expressed as
particle numbers per well per day, differed signifi-
cantly for 20-nm AgNPs from the rate of 50- and
75-nm AgNPs, both in the absence and presence of
FCS (Table 3). No difference in the uptake rate in the
presence of FCS could be observed for 50- and 75-nm
AgNPs, while the rate was higher for 50-nm AgNPs
than 75-nm AgNPs in the absence of FCS.
Discussion
Our results show that the tissue culture medium
composition in terms of the presence or absence of
foetal calf serum affects NP uptake significantly, as
confirmed by the literature (Sbarra and Karnovsky
1959; Ikada and Tabata 1986; Nagayama et al. 2007).
When no FCS is present, final concentrations after 24 h
expressed on a mass basis are higher for 50-nm AgNPs
than for 20- and 75-nm AgNPs. Internal cellular
concentrations, expressed as a percentage of the
nominal added concentrations, reached roughly 50 %
(20-, 75-nm NPs) and 65 % (50-nm NPs). FCS
decreases the amount of silver taken up on a mass basis
by roughly 25, 54 and 40 % for 20-, 50- and 75-nm
AgNPs, respectively. A possible explanation is the
formation of a protein corona around the AgNPs in the
medium with FCS that reduces their uptake. Anionic
bovine serum albumin, for example, showed repulsive
interaction with the negatively charged cell membrane
(Zhu et al. 2012). Recently, it was reported that also for
the uptake of fluorescent silica NPs, an increase in
serum concentration in the tissue culture medium
resulted in a decrease in cellular uptake in human
mesenchymal stemcells (hMSC) (Catalano et al. 2015).
We show the importance to consider various medium
compositions in toxicity studies, yet further confirma-
tion for NPs of different charge and various types of
serum proteins is needed. The higher uptake of 50-nm
particles on mass basis in absence of FCS might be
partially attributed to the more negative zeta potential
of these AgNPs. At first, a higher uptake of more
negatively charged NPs across the overall negatively
charged cell membrane seems illogical due to repul-
sion. Yet, an early study already reports that positively
charged patches on the cell surface exist (Ghinea and
Simionescu 1986). The positively charged residues
‘‘seem to be accumulated in coated pits’’ (Ghitescu and
Fixman 1984) and could, therefore, be responsible for
the binding and uptake of negatively charged NPs. An
increase in the absolute zeta potential usually leads to
increased NP uptake in comparison with less charged
NPs of the same size (Kettler et al. 2014). Whether size
or charge has the greater influence on uptake remains
unknown up to date due to a limited number of uptake
kinetics studies and a lack in availability of NPs with
proper characteristics to study these phenomena. This
stresses the need for commercially available NPs with
only one property changed at a time or, ideally, that
reference materials were made available.
Table 2 Overview of the uptake curves based on mass (ng) Ag
NP size (nm), medium type c Std. dev. of c 95 % CI of c
20 w/o FCS 4.2 9 10-2 n.a. n.a.
50 w/o FCS 1.1 9 10-1 4.0 9 10-3 1.1 9 10-1–1.2 9 10-1
75 w/o FCS 1.1 9 10-1 6.10 9 10-2 2.7 9 10-2–2.0 9 10-1
20?FCS 2.8 9 10-2 n.a. n.a.
50?FCS 2.9 9 10-2 1.6 9 10-2 6.9 9 10-3–5.2 9 10-2
75?FCS 4.8 9 10-2 2.9 9 10-2 7.5 9 10-3–8.8 9 10-2
Average uptake rate constants c, their standard deviation (Std. dev) and 95 % confidence interval (CI) based on NP mass, all given in
ng Ag well-1 d-1
n.a. not analysed
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In contrast to the uptake studies by Chithrani et al.
(2006) over 10 h, uptake did not always clearly level
off in time in our set-up (Fig. 1). This might be
attributed to the different elemental NP composition
(gold vs. Ag) (Ahsan et al. 2002) and different cell
lines (HeLa vs. 16HBE14o) as summarized by us
previously (Kettler et al. 2014); uptake of NPs also
shows a concentration dependency (Asharani et al.
2009; Chithrani et al. 2006; Giljohann et al. 2007;
Limbach et al. 2007). Giljohann et al. (2007) showed
that uptake does not necessarily relate to exposure
concentrations in a linear fashion. Catalano et al.
(2015) observed a levelling-off of the NP uptake in
hMSC in the presence of serum, whereas such a
levelling-off was not present in the testing conditions
without serum over a time course of only 6 h, what
makes a comparison with our results difficult. Yet, our
results show the opposite trend also for such short
incubation times. Overall, our results show that uptake
kinetics differ per NP and should be taken into account
in toxicity studies.
Although generally mass is used as dosing param-
eter (it is also highly practical and convenient) for
nanoparticles, the unit that reacts with a cell is the
whole particle. When mass is used as a dose for a
soluble chemical, this translates to a number of
Fig. 2 Average Ag content in cells on a NP number basis
calculated from the independent mass-based values for three NP
sizes andmediumwithout and with foetal calf serum as shown in
Fig. 1. The two top graphs show model data for all three NP
sizes for easy comparison and calculated average NP numbers
for 20-nm AgNPs. The four graphs on the bottom show the
average Ag content and the corresponding model data for 50-
and 75-nm AgNPs in more detail. Note: Due to logistic aspects,
the time points at which the samples have been obtained are
slightly shifted sometimes (maximum 1 h); different scaling on
the y axes
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molecules reacting with a cell or cell receptors.
Although nanoparticles also are composed of mole-
cules and these molecules can react with cell recep-
tors, due to its form (e.g. spheric, cube or tube like) not
all individual molecules can react with a cell or cell
receptor. It is the whole particle that can be composed
of a few but also many molecules depending on the
size (and size distribution) of the investigated
nanoparticle. So, a dose in mass, for nanoparticles,
cannot be translated in a dose of molecules interacting
with a cell or cell receptor. The dose in nanotoxicology
is still under debate and can be dependent on the toxic
parameter investigated. For example, for lung inflam-
mation the total surface area was found to be a better
dose description than mass (Braakhuis et al. 2016a).
Also, it is debated whether for in vitro cytotoxicity
experiments, the dose in the medium should be used
(in concentration of mass, surface area or particle
number) or the dose as what the cells see or take up
(DeLoid et al. 2015; Teeguarden et al. 2007).
It is also clearly shown that the measurand, in which
results are presented, plays a very important role in the
interpretation of the results. While in most cases, no
significant difference in uptake rate can be detected on
a mass basis, there is a very clear effect of particle size
on the uptake rate of 20-nm AgNPs when the results
are presented on a number of particle basis (Fig. 2).
Uptake of smaller particles is faster than of larger
particles independent of the culture medium compo-
sition; except for 50- and 75-nm AgNPs ? FCS, no
significant difference was observed, but the total mass
is equally fast, except for 20- and 50-nm AgNPs w/o
FCS. The size optimum, which relates to the highest
uptake rate, of 50 nm is only in good agreement with
other studies when expressed on a mass basis, while it
is not when expressed as particle number (Chithrani
et al. 2006; Shapero et al. 2010). In contrast to us, those
studies found the highest uptake rate at 50 nm based
on a particle number basis in various cell lines. Few
other studies exist where uptake rates have been
determined, yet they are difficult to compare to our
studies. The reason for this is the difference in the used
NP sizes. The following results are all converted to
and reported on NP number basis. Uptake rates are
found to be highest for 44 nm, followed by 114 and
33 nm (Varela et al. 2012). The other researchers find
32 nm to show highest uptake rates, followed by 70,
102, and 118 nm, respectively (Huang et al. 2010).
They originally report their results on mass basis; then,
the order is as follows: 102, 70, 118 and 32 nm. No
clear pattern can be observed on mass basis. Only one
of the few studies that also determine uptake rates is in
agreement with our results. Expressed on NP number
basis, uptake rates are also highest for 20-nm particles,
followed by 40 nm and lowest for 100 nm (Wang et al.
2009). Therefore, no conclusions about uptake optima
based on particle number basis can be directly drawn
even though all studied cell lines can utilize the
mechanism of endocytosis just as 16HBE cells. The
exact uptake mechanism for AgNPs into 16HBE cells
used in our experiments is unknown because the
determination of the exact uptake mechanism is very
complex. It requires the determination of the exact
concentration and incubation time for various inhibi-
tors and has to be adjusted for each cell line separately
(Kuhn et al. 2014). Pinocytosis can be excluded as the
uptake mechanism because it is a non-saturable
process and saturation is clearly observed (Fro¨hlich
2012).
The non-uniform way of presenting results may
lead to misinterpretation and false conclusion about
agreement between studies, as criticized by Le´vy et al.
Table 3 Overview of the uptake curves based on NP numbers (NP no.)
NP size (nm), medium type c Std. dev. of c 95 % CI of c
20 w/o FCS 1.0 9 106 n.a. n.a.
50 w/o FCS 1.4 9 105 4.7 9 103 1.3 9 105–1.4 9 105
75 w/o FCS 4.8 9 104 2.6 9 104 1.2 9 104–8.4 9 104
20?FCS 6.8 9 105 n.a. n.a.
50?FCS 3.5 9 104 1.9 9 104 8.2 9 103–6.1 9 104
75?FCS 2.1 9 104 1.3 9 104 3.2 9 103–3.8 9 104
Average uptake rate constants c, their standard deviation (Std. dev) and 95 % confidence interval (CI) based on NP number, all given
in NP number well-1 d-1
n.a. not analysed
 182 Page 8 of 11 J Nanopart Res  (2016) 18:182 
123
(2010). They showed that an optimum based on the
number of particles per cell does not necessarily lead
to the same optimum in terms of mass. This was also
nicely shown by Yue et al. (2010), who graphically
showed that the size optimum depends on the
measurand (number of particles per cell, particle
volume per cell and particle surface area per cell).
We therefore recommend to pay close attention to
the measurand given in various studies and would find
it helpful if the optimum was given also in different
measurands in one study for comparability between
studies. Often important data for such conversions are
not directly accessible in publications, e.g. it might be
difficult to calculate the number of atoms per particle
because only the total diameter is known but not the
thickness of a coating.
Conclusion
The present study shows that the medium composition
(absence or presence of FCS) has a large effect on the
speed of uptake and therefore the maximum concen-
tration after 24 h of exposure. This should be taken into
consideration in (toxicity) studies, where uptake and
internal concentration play a crucial role in the
understanding of the mechanism of the observed
effects. Uptake in medium without FCS shows a trend
towards higher uptake for 50-nm AgNPs than 75- and
20-nm AgNPs on a mass basis. This uptake optimum
shifts to 20-nm AgNPs when expressed on a AgNP
number basis in contrast to other results reported in the
literature. For comparability between studies, direct
conversion of uptake expressed asNPnumber andmass
in one publication is advantageous; sometimes, the
necessary information to do so oneself is not directly
available in the publication. Future developments will
greatly benefit from the use of reference materials.
Since the large and continuously growing number of
engineered NPs cannot all be covered experimentally,
comparability between studies would possibly help to
close knowledge gaps and allow for extrapolation
regarding uptake between different NPs by modelling.
Modelling will be an indispensable tool to cover the
large and continuously growing number of engineered
NPs and to predict the uptake of untested NPs.
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